Tasso Miliotis

AstraZeneca (United Kingdom)

Papers

1

Total Citations

3

H-Index

1

About

Tasso Miliotis is a distinguished researcher whose work sits at the critical intersection of proteomics and biomarker discovery, with a particular focus on bridging the gap between academic innovation and pharmaceutical industry application. His most cited work, "Implementation of a protein profiling platform developed as an academic‐pharmaceutical industry collaborative effort" (2008, 3 citations), exemplifies his commitment to translational science—developing robust protein profiling platforms that can accelerate the identification of diagnostic and prognostic assays for severe diseases. While his citation count may be modest, the significance of his contributions lies in the foundational, collaborative infrastructure he helped establish, enabling more efficient biomarker pipelines. Miliotis’s research addresses a pressing need in modern medicine: transforming proteomic discoveries into clinically actionable tools. His efforts highlight the importance of cross-sector partnerships in advancing precision medicine, making his work a valuable reference for students and researchers interested in the practical challenges of moving from bench to bedside in the proteomics field.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Implementation of a protein profiling platform developed as an academic‐pharmaceutical industry collaborative effort
3 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: AstraZeneca (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago